IL‐33 performs specialised functions via immune tolerance induction, and the feasibility of IL‐33 has been tested in acute graft‐versus‐host disease (GVHD) and inflammatory bowel disease (IBD), with promising results.21 The gene discussed is IL33; the disease is graft versus host disease.